由买买提看人间百态

boards

本页内容为未名空间相应帖子的节选和存档,一周内的贴子最多显示50字,超过一周显示500字 访问原贴
_pennystock版 - anyone familiar with ONTY
相关主题
ONTY 废了小猫咪,REGN
Re: ZT: EXEL今天生拉有点不象话了,呵呵
美小型生物制药股发出长期买入信号明天可以考虑的股票
小小蝌蚪明天可以考虑的股票
ONTY走势技术分析明天可以关注的股票
关于癌症Mentor Capital Cancer Immunotherapy Index奶奶的,ARIA
5月份药股FDA,NDA,试验数据公布时间表jamn现在1.4可不可以进场
光头:Biotech Stock Mailbag: Best Stocks to Watch in '11奶奶的,今年看好的全部上天了
相关话题的讨论汇总
话题: onty话题: familiar话题: anyone话题: dmc
1 (共1页)
n****e
发帖数: 4990
1
UP 10% with heavy volume but w/o any news
K********g
发帖数: 9389
2
光头据说讨论过这个股票,去光头专栏去看看吧

【在 n****e 的大作中提到】
: UP 10% with heavy volume but w/o any news
g**********1
发帖数: 399
3
Oncothyreon Initiates Phase 1/2 Trial of its PI-3 Kinase Inhibitor PX-866 in
Combination with Cetuximab, but dated two days ago
http://www.prnewswire.com/news-releases/oncothyreon-initiates-p
I have held it for almost one year...
n****e
发帖数: 4990
4
I guess here is the reason it jumps, but it is over
Oncothyreon Inc (ONTY) plunged 6.17 percent to $3.65 in the pre-market
trading. Merck Serono, a division of Merck KGaA of Darmstadt, Germany,
informed Oncothyreon on Dec. 22 that the Independent Data Monitoring
Committee (DMC) for the Phase 3 START trial of Stimuvax in non-small cell
lung cancer met and the DMC recommendation is to continue the study.

in

【在 g**********1 的大作中提到】
: Oncothyreon Initiates Phase 1/2 Trial of its PI-3 Kinase Inhibitor PX-866 in
: Combination with Cetuximab, but dated two days ago
: http://www.prnewswire.com/news-releases/oncothyreon-initiates-p
: I have held it for almost one year...

1 (共1页)
相关主题
奶奶的,今年看好的全部上天了ONTY走势技术分析
NND, 不该涨的都涨了, 该涨的不涨关于癌症Mentor Capital Cancer Immunotherapy Index
10 Biotech Trades for Second Half of 20115月份药股FDA,NDA,试验数据公布时间表
恭喜大耳饰光头:Biotech Stock Mailbag: Best Stocks to Watch in '11
ONTY 废了小猫咪,REGN
Re: ZT: EXEL今天生拉有点不象话了,呵呵
美小型生物制药股发出长期买入信号明天可以考虑的股票
小小蝌蚪明天可以考虑的股票
相关话题的讨论汇总
话题: onty话题: familiar话题: anyone话题: dmc